Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Increase in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a significant growth in short interest in the month of May. As of May 29th, there was short interest totaling 646,074 shares, a growth of 230.7% from the May 14th total of 195,368 shares. Based on an average daily trading volume, of 4,028,480 shares, the days-to-cover ratio is presently 0.2 days. Currently, 10.0% of the shares of the stock are short sold.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on AMIX shares. Weiss Ratings downgraded shares of Autonomix Medical from a “sell (e+)” rating to a “sell (e)” rating in a report on Wednesday, June 3rd. Maxim Group decreased their price target on Autonomix Medical from $5.00 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, February 17th. Finally, Zacks Research raised shares of Autonomix Medical to a “hold” rating in a research note on Tuesday, June 2nd. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $2.00.

Autonomix Medical Stock Down 1.7%

AMIX stock traded down $0.01 during mid-day trading on Thursday, reaching $0.37. The company had a trading volume of 8,566 shares, compared to its average volume of 939,922. The stock’s 50-day simple moving average is $0.38 and its two-hundred day simple moving average is $0.48. Autonomix Medical has a one year low of $0.20 and a one year high of $2.64. The stock has a market capitalization of $2.57 million, a P/E ratio of -0.10 and a beta of -1.43.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.